Checchi Capital Advisers LLC cut its holdings in Medtronic plc (NYSE:MDT – Free Report) by 13.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,954 shares of the medical technology company’s stock after selling 888 shares during the period. Checchi Capital Advisers LLC’s holdings in Medtronic were worth $469,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. LifeSteps Financial Inc. purchased a new stake in shares of Medtronic during the 1st quarter worth approximately $27,000. MeadowBrook Investment Advisors LLC purchased a new stake in shares of Medtronic during the 4th quarter worth approximately $27,000. Lynx Investment Advisory bought a new position in shares of Medtronic during the 2nd quarter valued at approximately $28,000. Tributary Capital Management LLC bought a new position in shares of Medtronic during the 1st quarter valued at approximately $33,000. Finally, Riverview Trust Co bought a new position in shares of Medtronic during the 1st quarter valued at approximately $39,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Medtronic news, CEO Geoffrey Martha sold 19,113 shares of the stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $83.77, for a total value of $1,601,096.01. Following the completion of the sale, the chief executive officer now directly owns 143,348 shares in the company, valued at $12,008,261.96. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.30% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Check Out Our Latest Research Report on MDT
Medtronic Price Performance
MDT opened at $88.33 on Thursday. The company has a current ratio of 2.03, a quick ratio of 1.55 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $113.26 billion, a price-to-earnings ratio of 32.12, a PEG ratio of 2.35 and a beta of 0.82. Medtronic plc has a 12-month low of $68.84 and a 12-month high of $90.13. The business’s fifty day simple moving average is $80.85 and its 200-day simple moving average is $82.33.
Medtronic (NYSE:MDT – Get Free Report) last issued its quarterly earnings data on Tuesday, August 20th. The medical technology company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. The firm had revenue of $7.97 billion during the quarter, compared to analysts’ expectations of $7.90 billion. Medtronic had a return on equity of 13.47% and a net margin of 11.36%. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.20 EPS. On average, equities research analysts anticipate that Medtronic plc will post 5.44 earnings per share for the current fiscal year.
Medtronic Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 3.17%. The ex-dividend date of this dividend is Friday, September 27th. Medtronic’s dividend payout ratio (DPR) is currently 101.82%.
Medtronic Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
See Also
- Five stocks we like better than Medtronic
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks to Watch as the Dollar Declines to a 7-Month Low
- The 3 Best Fintech Stocks to Buy Now
- MGM Insiders Bet Big on Its Undervalued Stock
- What to Know About Investing in Penny Stocks
- BHP Stock: The Under-the-Radar Growth Story in Commodities
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT – Free Report).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.